Product Overview Retatrutide is a novel synthetic peptide extensively studied in preclinical research for its potential role in metabolic signaling, appetite regulation, and energy balance. As a triple-agonist peptide, Retatrutide interacts with GLP-1, GIP, and glucagon receptors, making it a focus of research in obesity, glucose metabolism, and weight management pathways. Its stability in lyophilized form ensures consistent results in laboratory studies.
Key Research Focus Areas
Metabolic signaling and energy homeostasis
Appetite modulation and satiety mechanisms
Glucose regulation and insulin sensitivity
Weight management and adipose tissue studies
Cellular signaling pathways involving GLP-1, GIP, and glucagon receptors
Format Options
10 mg or 20 mg 30 mg lyophilized powder
Optional BAC solvent available separately
Important Notice All products are sold for laboratory research use only. Not for human consumption, injection, or diagnostic use.
